用于胃食管反流病的现代磁性植入物
磁性括约肌增强装置于2012年获美国食品药品监督管理局批准,用于治疗胃食管反流病。5年FDA试验显示多数患者达到正常pH评分,85%停用质子泵抑制剂,胃食管反流病健康相关生活质量症状评分从27改善至4;7项研究比较磁力增强与腹腔镜Nissen胃底折叠术,疗效相当,但尚无随机对照试验。
要点
- 磁性装置环绕胃食管连接部,增强天然下食管括约肌并保留其生理功能,允许嗳气和呕吐。
- 5年FDA试验中85%患者停用质子泵抑制剂,症状评分从27改善至4。
- 与腹腔镜Nissen胃底折叠术相比疗效相当,但尚无随机对照试验直接比较。
核心结论
- 磁性括约肌增强是治疗胃食管反流病安全有效的手术,对于希望保留胃底的患者,尤其是参数与研究队列一致者,应考虑作为手术选择。
- 额外的随机对照试验正在进行中。
研究设计与样本
- 综述性文章,汇总多项患者队列研究、一项5年FDA试验及7项与腹腔镜Nissen胃底折叠术比较的研究。
- 原文未报告系统检索范围。
主要发现
- 5年FDA试验显示多数患者达到正常pH评分,85%停用质子泵抑制剂,胃食管反流病健康相关生活质量症状评分从27改善至4(5年时)。
- 7项研究比较磁力增强与腹腔镜Nissen胃底折叠术,在停用质子泵抑制剂、胃食管反流病症状评分改善及烧心和反流评分方面疗效相当。
- 两组吞咽困难发生率相似,再手术率和安全性特征相当,但磁性装置在允许嗳气和呕吐方面显示显著有益差异。
- 装置移除率在临床试验中为0%至7%,且均无事件发生;FDA临床试验中无糜烂、穿孔或感染,实践中糜烂罕见。
关键数值与推荐
- 主要不良事件为吞咽困难,慢性发生率约3%-5%。
- 装置移除率在临床试验中为0%至7%。
- 5年FDA试验中85%患者停用质子泵抑制剂,症状评分从27改善至4。
临床怎么用
- 磁性括约肌增强应考虑作为希望保留胃底的手术选择,尤其适用于参数与研究队列一致的患者。
- 原文未报告本研究中心做法。
局限性
- 尚无随机对照试验比较磁性装置与腹腔镜Nissen胃底折叠术。
- 研究队列在食管裂孔疝大小、反流严重程度、体重指数评分或食管炎评分方面不一定具有可比性。
- 额外的随机对照试验正在进行中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A magnetic implant for the treatment of gastroesophageal reflux disease (GERD) was Food and Drug Administration-approved in 2012 and has been extensively evaluated. The device is a ring of magnets that are placed around the gastroesophageal junction, augmenting the native lower esophageal sphincter and preventing reflux yet preserving lower esophageal sphincter physiologic function and allowing belching and vomiting. Magnetic force is advantageous, being permanent and precise, and forces between magnets decrease with esophageal displacement. Multiple patient cohorts have been studied using the magnetic device, and trials establish consistent, long-term improvement in pH data, GERD symptom scores, and proton-pump inhibitor use. A 5-year Food and Drug Administration trial demonstrated that most patients achieved normal pH scores, 85% stopped proton-pump inhibitors, and GERD health-related quality of life symptom scores improved from 27 to 4 at 5 years. Seven studies have compared magnetic augmentation with laparoscopic Nissen fundoplication and demonstrated that the magnetic device achieved comparable efficacy with regard to proton-pump inhibitor cessation, GERD symptom score improvement, and heartburn and regurgitation scores. However, to date there have been no randomized, controlled trials comparing the 2 techniques, and the study cohorts are not necessarily comparable regarding hiatal hernia size, severity of reflux, body mass index scores, or esophagitis scores. Dysphagia incidence was similar in both groups. Reoperation rates and safety profiles were also comparable, but the magnetic device demonstrated significant beneficial differences in allowing belching and vomiting. The magnetic device is safe, with the main adverse event being dysphagia with an approximate 3%-5% chronic incidence. Device removals in clinical trials have been between 0% and 7% and were uneventful. There have been no erosions, perforations, or infections in FDA clinical trials; erosions have rarely been noted in practice. Magnetic augmentation of the lower esophageal sphincter is a safe and effective operation for GERD, and should be considered a surgical option for those seeking a fundic-sparing operation, particularly those with parameters consistent with study cohorts. Additional randomized, controlled trials are underway.
引用
- Ganz RA. A Modern Magnetic Implant for Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol. 2016. PMID: 28025156. doi:10.1016/j.cgh.2016.12.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。